--- title: "Healthy Extracts Inc. | 10-K: FY2025 Revenue: USD 4.512 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/283993332.md" datetime: "2026-04-24T11:39:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283993332.md) - [en](https://longbridge.com/en/news/283993332.md) - [zh-HK](https://longbridge.com/zh-HK/news/283993332.md) --- # Healthy Extracts Inc. | 10-K: FY2025 Revenue: USD 4.512 M Revenue: As of FY2025, the actual value is USD 4.512 M. EPS: As of FY2025, the actual value is USD -0.09. EBIT: As of FY2025, the actual value is USD -733.57 K. ### Consolidated Financial Performance #### Revenue Healthy Extracts Inc. reported revenues of $4,511,997 for the year ended December 31, 2025, marking a 45% increase from $3,113,279 in 2024. #### Cost of Revenue and Gross Profit The cost of revenue increased by 74% to $2,089,506 in 2025 from $1,201,959 in 2024. This resulted in a gross profit of $2,422,491 in 2025, up 27% from $1,911,320 in the prior year. The cost of revenue as a percentage of total revenues was 46% in 2025, compared to 39% in 2024. #### Operating Expenses and Net Loss General and administrative expenses increased by 108% to $3,366,341 in 2025 from $2,094,469 in 2024, primarily due to higher advertising spend and stock-based compensation. Other income (expense) showed a gain of $62,731 in 2025, a significant change from a - $657,522 expense in 2024. The net loss for 2025 was - $881,119, slightly higher than the - $840,671 net loss in 2024. The company’s accumulated deficit reached $20,121,462 as of December 31, 2025. ### Liquidity and Capital Resources #### Cash and Assets As of December 31, 2025, cash on hand was $146,935, an increase of $34,916 from $112,020 in 2024. Total current assets decreased to $1,327,317 in 2025 from $1,659,387 in 2024, mainly due to a - $517,859 decrease in inventory, partially offset by a $176,747 increase in accounts receivable. Total assets significantly increased to $27,824,664 in 2025 from $2,377,973 in 2024, driven by increases in fixed assets, goodwill, and right-of-use assets. #### Liabilities Total current and non-current liabilities rose to $3,795,099 in 2025 from $1,967,596 in 2024. #### Cash Flow Net cash from operating activities was $165,520 in 2025, down from $281,968 in 2024. Net cash provided by investing activities was $56,301 in 2025, compared to zero in 2024. Net cash used in financing activities was - $186,906 in 2025, compared to - $189,389 in 2024. ### Segment Performance (Year Ended December 31, 2025) #### Revenue by Segment - **Consolidated**: $4,511,997 - **BergaMet**: $3,751,247 - **Gummy USA**: $760,750 #### Cost of Revenue by Segment - **Consolidated**: $2,433,103 - **BergaMet**: $2,219,096 - **Gummy USA**: $214,007 #### Gain (Loss) Before Tax by Segment - **Consolidated**: - $881,119 - **BergaMet**: $53,408 - **Gummy USA**: - $154,242 - **UBN**: - $300 - **Corporate**: - $779,985 #### Long-lived Assets by Segment - **Consolidated**: $1,140,342 - **BergaMet**: $186,978 - **Gummy USA**: $450,637 - **UBN**: $502,727 #### Identifiable Assets by Segment - **Consolidated**: $843,357 - **BergaMet**: $737,862 - **Gummy USA**: $105,495 #### Depreciation & Amortization by Segment - **Consolidated**: $152,192 - **BergaMet**: $1,963 - **Gummy USA**: $150,229 ### Segment Performance (Year Ended December 31, 2024) #### Revenue by Segment - **Consolidated**: $3,113,279 - **BergaMet**: $3,113,279 #### Cost of Revenue by Segment - **Consolidated**: $1,207,982 - **BergaMet**: $1,207,982 #### Gain (Loss) Before Tax by Segment - **Consolidated**: - $840,871 - **BergaMet**: $362,171 - **UBN**: - $1,244 - **Corporate**: - $1,201,798 #### Long-lived Assets by Segment - **Consolidated**: $732,030 - **BergaMet**: $193,260 - **UBN**: $538,771 #### Identifiable Assets by Segment - **Consolidated**: $1,361,216 - **BergaMet**: $1,361,216 #### Depreciation & Amortization by Segment - **Consolidated**: $140 - **BergaMet**: $140 ### Outlook / Guidance Healthy Extracts Inc. anticipates revenue growth to continue as direct consumer sales and marketing efforts remain effective. The company plans to expand its product portfolio with new health products, including supplements for CoQ10, weight management, hydration, and gut health, expected to be ready for manufacturing in early 2025. Additionally, Healthy Extracts Inc. will continue to explore strategic acquisition opportunities to broaden its product offerings and leverage its marketing and distribution strengths. ### Related Stocks - [HYEX.US](https://longbridge.com/en/quote/HYEX.US.md) ## Related News & Research - [Vertical Aerospace (EVTL) Q4 2025 Earnings Transcript](https://longbridge.com/en/news/289059725.md) - [FSSAI mandates 'vegan' logo on all approved food packages from July 2027](https://longbridge.com/en/news/288816194.md) - [Op-Ed: Back in Hai Phong and the Third Time’s Even More Electrifying](https://longbridge.com/en/news/289292333.md) - [ZAWYA: Talaat Moustafa Group dominates Egypt’s North Coast market with $2.50bln in 2025 sales](https://longbridge.com/en/news/289013023.md) - [Big Digital Energy Ends 2024 AI/HPC Colocation Agreement With BE Global Development](https://longbridge.com/en/news/289236242.md)